Cellular and molecular gastroenterology and hepatology · 2026
Spatial Analysis of Intraductal Papillary Mucinous Neoplasms Defines a Paradoxical Keratin 17-Positive, Low-Grade Epithelial Population Harboring Malignant Features.
СтатьяПоддержка исследования: вне правительства СШАПоддержка правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Li Jay, Branch Georgina, Macchia Justin, Elhossiny Ahmed M, Arya Nandini, Liang Julia, Kadiyala Padma, Peterson Nicole, Kwon Richard, Machicado Jorge D, Wamsteker Erik-Jan, Schulman Allison, Philips George, Menees Stacy, Xia Jonathan, Singhi Aatur D, Sahai Vaibhav, Fang Jiayun M, Frankel Timothy L, Bednar Filip, Pasca di Magliano Marina, Shi Jiaqi, Carpenter Eileen S
Аннотация
BACKGROUND & AIMS: Intraductal papillary mucinous neoplasms (IPMNs) are pancreatic cysts that represent one of the few radiologically identifiable precursors to pancreatic ductal adenocarcinoma (PDAC). Although the IPMN-bearing patient population represents a unique opportunity for early detection and interception, current guidelines provide insufficient accuracy in determining which patients should undergo resection vs surveillance, resulting in a sizable fraction of resected IPMNs only harboring low-grade dysplasia, suggesting that there may be overtreatment of this clinical entity.
METHODS: To investigate the transcriptional changes that occur during IPMN progression, we performed spatial transcriptomics using the Nanostring GeoMx on patient samples containing the entire spectrum of IPMN disease including low-grade dysplasia, high-grade dysplasia, and IPMN-derived carcinoma. Single-cell RNA sequencing was performed on side branch and main duct IPMN biospecimens.
RESULTS: We identified a subpopulation of histologically low-grade IPMN epithelial cells that express malignant transcriptional features including KRT17, S100A10, and CEACAM5, markers that are enriched in PDAC. We validated this high-risk gene signature in both single-cell RNA sequenced samples and an external spatial transcriptomic dataset containing a larger number of IPMN samples with non-tumor bearing IPMN (ie, low-grade IPMN in isolation). Immunofluorescence staining of a large cohort of patient tissues confirmed the presence of Keratin 17-positive cells, which were found to comprise a small subset of epithelial cells within histologically low-grade IPMN in a patchy distribution.
CONCLUSIONS: Our study demonstrates that Keratin 17 marks a distinct transcriptional signature in a subpopulation of epithelial cells within histologically low-grade IPMN. This population of cells likely represents a transitional state of histologically low-grade epithelial cells undergoing progression to a higher grade of dysplasia and thus may represent a higher risk of progression to carcinoma.
METHODS: To investigate the transcriptional changes that occur during IPMN progression, we performed spatial transcriptomics using the Nanostring GeoMx on patient samples containing the entire spectrum of IPMN disease including low-grade dysplasia, high-grade dysplasia, and IPMN-derived carcinoma. Single-cell RNA sequencing was performed on side branch and main duct IPMN biospecimens.
RESULTS: We identified a subpopulation of histologically low-grade IPMN epithelial cells that express malignant transcriptional features including KRT17, S100A10, and CEACAM5, markers that are enriched in PDAC. We validated this high-risk gene signature in both single-cell RNA sequenced samples and an external spatial transcriptomic dataset containing a larger number of IPMN samples with non-tumor bearing IPMN (ie, low-grade IPMN in isolation). Immunofluorescence staining of a large cohort of patient tissues confirmed the presence of Keratin 17-positive cells, which were found to comprise a small subset of epithelial cells within histologically low-grade IPMN in a patchy distribution.
CONCLUSIONS: Our study demonstrates that Keratin 17 marks a distinct transcriptional signature in a subpopulation of epithelial cells within histologically low-grade IPMN. This population of cells likely represents a transitional state of histologically low-grade epithelial cells undergoing progression to a higher grade of dysplasia and thus may represent a higher risk of progression to carcinoma.
Предметные рубрики MeSH
HumansPancreatic Intraductal NeoplasmsCarcinoma, Pancreatic DuctalPancreatic NeoplasmsFemaleMaleEpithelial CellsSpatial TranscriptomicsBiomarkers, TumorAdenocarcinoma, MucinousGene Expression Regulation, NeoplasticAgedMiddle AgedDisease ProgressionSingle-Cell Gene Expression AnalysisPancreatic CystSingle-Cell AnalysisCarcinoembryonic AntigenKeratin-17GPI-Linked Proteins